Form EFFECT ADIAL PHARMACEUTICALS,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 17, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sunny Creek Modulars Earns CSA Certification for Year-Round Manufactured Homes
- Salazar Resources Files NI 43-101 Technical Report for the Curipamba-El Domo Project
- PR0948 - Kimoukro Gold Project Maiden Diamond Drilling Results and Phase 2 Exploration Strategy
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share